Tarsus Pharmaceuticals, Inc.TARSNASDAQ
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+111.8%
5Y CAGR+122.0%
Year-over-Year Change
Selling, general, and administrative expenses
3Y CAGR
+111.8%/yr
vs +216.5%/yr prior
5Y CAGR
+122.0%/yr
Recent deceleration
Acceleration
-104.6pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
53.9x
Strong expansion
Streak
7 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $427.32M | +80.1% |
| 2024 | $237.31M | +118.3% |
| 2023 | $108.70M | +141.8% |
| 2022 | $44.95M | +77.0% |
| 2021 | $25.40M | +220.4% |
| 2020 | $7.93M | +646.3% |
| 2019 | $1.06M | +137.1% |
| 2018 | $448000.00 | - |